Drug Type Small molecule drug |
Synonyms |
Target |
Action antagonists |
Mechanism CCR3 antagonists(C-C chemokine receptor type 3 antagonists), H1 receptor antagonists(Histamine H1 receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC28H30FN5O2 |
InChIKeyOIXSYJAHIPQFMO-RUZDIDTESA-N |
CAS Registry671205-14-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Discovery | Japan | - |